Physician profile
Michael Happes
NPI 1801030762
$29,702.75
in general payments reported to CMS, 2019-2025
26 companies · $4,888 in 2025
The $4,888 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,993 · 2020: $974 · 2021: $3,701 · 2022: $3,010 · 2023: $2,059 · 2024: $12K · 2025: $4,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,525 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Consulting Fee: $3,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,525.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Consulting Fee | $3,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,409.07 | 2019-2025 | Ultreon, Dragonfly Opstar, Xience Sierra |
| Medtronic, INC. | $3,061.54 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Inari Medical, INC. | $2,444.85 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $1,780.59 | 2021-2025 | Impella |
| Medtronic Vascular, INC. | $817.98 | 2019-2020 | |
| Stryker Corporation | $674.72 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $595.05 | 2024-2025 | |
| Edwards Lifesciences Corporation | $437.56 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $375.29 | 2019-2025 | Watchman Flx, Accolade Sr, Rotapro |
| Penumbra, INC. | $343.93 | 2025 | Indigo System, Penumbra System |
| Philips North America LLC | $234.21 | 2019-2024 | (5091) Amb Mon & Diag Und |
| Atricure, INC. | $221.92 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $208.98 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $196.81 | 2021-2025 | Camzyos, Eliquis |
| Veryan Medical Incorporated | $153.89 | 2023 | Biomimics 3d Vascular Stent System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $143.56 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $143.37 | 2019-2022 | |
| Pfizer INC. | $121.02 | 2019-2024 | |
| Amgen INC. | $92.37 | 2021-2024 | Repatha |
| Shockwave Medical, INC | $68.97 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.00 | 2022-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $39.55 | 2022-2024 | |
| Kestra Medical Technology Services, INC. | $30.93 | 2025 | Assure Wcd |
| Heartflow, INC. | $23.98 | 2022 | |
| Novo Nordisk INC | $18.30 | 2023 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $13.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Happes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.